stocktools
Dilution profile // every instrument, one screen, from SEC filings

Bolt Biotherapeutics, Inc. (BOLT)

CIK 1641281 · all EDGAR filings →

Overall dilution risk
HIGHworst of 3 computed signals (offering ability)
= the worst band among the computed sub-ratings, no hidden weighting
not every sub-rating was computable; treat as a floor
Offering ability
HIGHS-3 on file 2022-03-30
= is there a registration (S-1/S-3 family) on file without a later withdrawal
no structured fee data on the live registrations, so this is a yes/no, not a size
Overhead supply
NOT COMPUTEDno warrant count tagged in XBRL
= warrant shares outstanding divided by current shares outstanding
absence of a tag is not proof of absence of warrants
Historical dilution
LOW-95% O/S in 3y
= share count now vs 3 years ago (bands: 30% / 100%); a reverse split pushes this negative
a reverse-split-sized cliff is in this window; read the chart
Cash need
HIGH~5.3 months of runway
= cash vs trailing operating burn (bands: 6mo / 24mo; positive operating CF = low)
the company itself flagged going-concern doubt

Same rating bands the category standard uses, but free, with the formula on the chip and the gaps in the data said out loud.

Shares outstanding over time

2021-05-102026-08-04

Latest: 1.9M shares as of Aug 4, 2026 (10-Q). Share count fell from 38.3M to 1.9M between May 5, 2025 and Aug 7, 2025, a pattern consistent with a reverse split (roughly 1-for-20); simultaneous issuance can skew the raw ratio, so confirm in the filings. The red bar marks the cliff.

Cash runway

Going-concern warning

auditor flagged substantial doubt

The company itself flagged going-concern doubt in a filing.

Full breakdown: cash runway tool · source filing →

Warrants

No warrant figures tagged in this filer’s XBRL facts. That means the company has not reported them in structured form; it does not prove no warrants exist. The exhibits are the ground truth.

Convertible notes

No convertible-note facts tagged in the 10-Q filed Aug 11, 2026. If convertible notes exist, their terms live in exhibit prose for this filer and are not parsed; absence of a tag is not proof of absence. The exhibits are the ground truth.

Registrations and offerings

Last 12 months: 0 executed · 0 registered.

EXECUTEDApr 7, 2022Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)424B5 →
EFFECTIVEApr 7, 2022SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDMar 30, 2022S-3 registration — capacity to sell shares, not a sale yetS-3 →
EXECUTEDFeb 5, 2021Final prospectus — offering priced (typical for IPOs and marketed share deals)424B4 →
REGISTEREDFeb 4, 2021S-1MEF registration — capacity to sell shares, not a sale yetS-1MEF →
EFFECTIVEFeb 4, 2021SEC declared a registration effective — selling can beginEFFECT →
REGISTEREDFeb 3, 2021S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDFeb 1, 2021S-1/A registration — capacity to sell shares, not a sale yetS-1/A →
REGISTEREDJan 15, 2021S-1 registration — capacity to sell shares, not a sale yetS-1 →

Full history and shelf status: offering checker · S-3 shelf checker

Source: SEC EDGAR XBRL company facts and filing metadata, fetched live and cached briefly. Share counts are cover-page figures with their form named. Warrant tranches and convertible notes come from the dimensioned facts in the latest 10-Q/10-K instance document, exactly as the company tagged them; untagged tranches and notes are absent, not disproven. Nothing on this page is manually verified and nothing is behind a login: what free data supports is shown, what it cannot support is stated. Not investment advice.

Keep going: float checker · offering calendar · short-squeeze screener · full BOLT workspace